Cathepsin Inhibitor 2
Cathepsin Inhibitor 2 is a potent Cathepsin S inhibitor extracted from patent WO2009123623A1, has a Ki of <20 nM.
Product Specifications
CAS Number
[1017931-53-1]
UNSPSC
12352005
Target
Cathepsin
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
COVID-19-immunoregulation
Field of Research
Cancer; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/Heptanamide,_N-_1-cyanocyclopropyl_-4,4-difluoro-2-[[_1S_-2,2,2-trifluoro-1-_4-fluorophenyl_ethyl]amino]-,__2S_-.html
Concentration
10mM
Purity
98.05
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
FC(F)(F)[C@H](C1=CC=C(F)C=C1)N[C@@H](CC(F)(F)CCC)C(NC2(CC2)C#N)=O
Molecular Formula
C19H21F6N3O
Molecular Weight
421.38
References & Citations
[1]LINK, John, O, et al. DI-FLUORO CONTAINING COMPOUNDS AS CYSTEINE PROTEASE INHIBITORS. WO2009123623A1.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
Cathepsin S
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![Recombinant Human Glutamate [NMDA] receptor subunit 3A (GRIN3A) , partial](https://cdn.genprice.uk/genprice/uk/genprice5.webp)
Recombinant Human Glutamate [NMDA] receptor subunit 3A (GRIN3A) , partial
